Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on May 20, 2025

Women Grow Expands Partnership with Benzinga Capital Conference to Unite Women Entrepreneurs
Women-led initiatives, including the #InvestinHER Lounge, First Pour, and Canna …

Laser Hair Removal Gains Popularity as a Long-Term Hair Reduction Solution
Laser Hair Removal Gains Popularity as a Long-Term Hair Reduction Solution CHICAGO, IL, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Dr. Sam Speron, a renowned plastic and reconstructive surgeon, is proud to introduce Laser Hair Removal, a state-of …

Indiana women gain new confidence in breast cancer surgery: Parkview Health first to install VSI-360
Indiana's first 3D intraoperative specimen imaging system CHICAGO, IL, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Clarix Imaging, a medical technology company pioneering the first intraoperative 3D CT imaging system for real-time, high-resolution …

Blackwell Captive Solutions Partners with Outfox Health to Deliver AI-Powered Benefits Navigation to Captive Members
First-of-its-kind partnership leverages multilingual, mobile-first AI navigation to drive utilization, cut waste, and support diverse workforces. CHICAGO, IL, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Blackwell Captive Solutions, a next- …

UMF Corporation Launches RPM™ Product Line to Revolutionize Cleaning in Critically Controlled Environments
UMF Corporation unveils RPM™, a 10-piece system revolutionizing cleaning in high-risk environments like compounding pharmacies and restoration sites. NORTHBROOK, IL, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- UMF Corporation, a recognized leader …

Online Marketing for Doctors Delivers Exceptional Growth Results for Medical Professionals
Online Marketing for Doctors empowers healthcare professionals worldwide to achieve rapid, measurable growth through specialized digital strategies. Their clients report major boosts in website traffic, patient inquiries, and marketing efficiency, while …

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully upsized its offering and priced approximately $2,300,000,000 (equivalent) of its senior notes (the “ …

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the Company’s new Chief …

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44 …

Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly announces its strategic amalgamation with Klonetics Plant Science Inc., a licensed cannabis nursery and …

Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio invitro …

TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category
SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- TrialWire today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Outstanding Patient Recruitment and Retention category. TrialWire is the AI and algorithm-powered patient- …

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to BB+, with a stable outlook; from BB. Fitch's report cites …

Neuphoria Provides First Quarter 2025 Business Updates
Cash runway into Q3 2026 AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025 α7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s …

XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport …

CooperCompanies’ 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet
SAN RAMON, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (“Cooper”) (Nasdaq: COO), a leading medical device company, published its 2024 Sustainability Report. The report showcases the company’s initiatives to foster positive change for both …

GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie
Lille (France), Cambridge (Massachusetts, Etats-Unis), Zurich (Suisse), le 20 mai, 2025 – GENFIT (Nasdaq et Euronext : GNFT), société́ biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares …

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate …

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane …